Drugs / Hualan TIV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03344029 Comparator | Nov 2017 → May 2018 | influenza | Sanofi | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hualan TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03344029 ↗ |
| Modality | Vaccine | “trivalent inactivated influenza vaccine” NCT03344029 ↗ |
| Route | Intramuscular | “0.5 mL, intramuscular into the deltoid muscle” NCT03344029 ↗ |